Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Much ground already covered by joint assessments of EU notified bodies, but more needed

This article was originally published in Clinica

Executive Summary

Joint assessments by national designating authorities of notified bodies active in the medical device area are relatively new. A voluntary program related to these assessments kicked off in January 2013 and the initiative has already seen much action. While those orchestrating this program are pleased at what has been achieved, more intense scrutiny is on the way and the European Parliament wants even more. Amanda Maxwell reports

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT101066

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel